Among the 18 compounds identified as positive hits, resveratrol was the one with the best frataxin-inducing capacity in fibroblasts and lymphoblasts from FRDA patients, and the one having lesser toxic cell effects (Li et al., 2013). The gene discussed is FXN; the disease is Friedreich ataxia.